Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomedical chromotography

• Publication date

  2011-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/bmc.1555PMID 21154885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.

  2010cited by this paper
• Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.

  2010cited by this paper
• Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls

  2009cited by this paper
• Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.

  2009cited by this paper
• Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry.

  2008cited by this paper
• Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies.

  2008cited by this paper
• Stability of benzodiazepines and cocaine in blood spots stored on filter paper.

  2008cited by this paper
• Determination of Morphine and 6-Acetylmorphine in Blood With Use of Dried Blood Spots

  2008cited by this paper
• What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research

  2007cited by this paper
• Discovery stage pharmacokinetics using dried blood spots.

  2004cited by this paper
• Use of filter paper for the collection and analysis of human whole blood specimens.

  2001cited by this paper
• Bioassay quantitation of ramoplanin in human and in nonprimate sera.

  1994cited by this paper

• Tutorial review for peptide assays: An ounce of pre-analytics is worth a pound of cure.

  2023cites this paper
• Dried Blood Spot Sampling in Protein and Peptide Bioanalysis: Optimism, Experience, and the Path Forward

  2023cites this paper
• Simultaneous Determination of Active Clinical Components of Teicoplanin and Ramoplanin in Environmental Water by LC-MS/MS Coupled With Cascade Elution

  2021cites this paper
• Development and validation of an LC-MS/MS method for relevant drugs in epilepsy patients using dried blood spots.

  2021cites this paper
• A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients.

  2020cites this paper
• Official International Association for Therapeutic Drug Monitoring and Toxicology guideline: Development and Validation of Dried Blood Spot-based Methods for Therapeutic Drug Monitoring.

  2019cites this paper
• Quantitative analysis of clofazimine (Lamprene®), an antileprosy agent, in human dried blood spots using liquid chromatography-tandem mass spectrometry.

  2018cites this paper
• Clinical application of microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: a systematic review.

  2018cites this paper
• Expanding the knowledge on dried blood spots and LC-MS-based protein analysis: two different sampling materials and six protein targets

  2017cites this paper
• Opening the toolbox of alternative sampling strategies in clinical routine: A key-role for (LC-)MS/MS

  2016cites this paper
• Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?

  2016cites this paper
• The use of mass spectrometry to analyze dried blood spots.

  2016influential citation
• Is there a role for microsampling in antibiotic pharmacokinetic studies?

  2016cites this paper
• Mass spectrometric quantification of amyloid-beta in cerebrospinal fluid and plasma

  2015cites this paper
• Water-Soluble Dried Blood Spot in Protein Analysis: A Proof-of-Concept Study.

  2015cites this paper
• Liquid chromatography tandem mass spectrometry in the clinical laboratory

  2015cites this paper
• Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.

  2014cites this paper
• Improved liquid-liquid extraction with inter-well volume replacement dilution workflow and its application to quantify BMS-927711 in rat dried blood spots by UHPLC-MS/MS.

  2014cites this paper
• Dried blood spots: concepts, present status, and future perspectives in bioanalysis.

  2014cites this paper
• Bioanalysis and clinical pharmacology of tamoxifen in breast cancer

  2014influential citation
• Direct Analysis of Dried Blood Spot Samples

  2014cites this paper
• Dried blood spots: analysis and applications.

  2013cites this paper
• Recent advances in the bioanalysis of peptide and protein therapeutics

  2013cites this paper
• Bioanalysis of Biotherapeutics

  2013cites this paper
• Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport

  2013cites this paper
• Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing

  2012cites this paper
• Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment.

  2012cites this paper
• The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome.

  2012cites this paper
• Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.

  2011cites this paper
• Approaches to Analyzing Therapeutic Peptides and Proteins by LC-MS / MS

  2010cites this paper